94 related articles for article (PubMed ID: 16055674)
21. Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling.
Deroanne CF; Bonjean K; Servotte S; Devy L; Colige A; Clausse N; Blacher S; Verdin E; Foidart JM; Nusgens BV; Castronovo V
Oncogene; 2002 Jan; 21(3):427-36. PubMed ID: 11821955
[TBL] [Abstract][Full Text] [Related]
22. Endothelial cell spheroids as a versatile tool to study angiogenesis in vitro.
Heiss M; Hellström M; Kalén M; May T; Weber H; Hecker M; Augustin HG; Korff T
FASEB J; 2015 Jul; 29(7):3076-84. PubMed ID: 25857554
[TBL] [Abstract][Full Text] [Related]
23. Microencapsulated VEGF gene-modified umbilical cord mesenchymal stromal cells promote the vascularization of tissue-engineered dermis: an experimental study.
Han Y; Tao R; Han Y; Sun T; Chai J; Xu G; Liu J
Cytotherapy; 2014 Feb; 16(2):160-9. PubMed ID: 24438897
[TBL] [Abstract][Full Text] [Related]
24. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
25. Antiproliferative and antiangiogenic effects of 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, in human umbilical vascular endothelial cells.
Juan SH; Lee JL; Ho PY; Lee YH; Lee WS
Eur J Pharmacol; 2006 Jan; 530(1-2):1-8. PubMed ID: 16359657
[TBL] [Abstract][Full Text] [Related]
26. Role of Src in angiopoietin 1-induced capillary morphogenesis of endothelial cells: Effect of chronic hypoxia on Src inhibition by PP2.
Kanda S; Kanetake H; Miyata Y
Cell Signal; 2007 Mar; 19(3):472-80. PubMed ID: 16949254
[TBL] [Abstract][Full Text] [Related]
27. A new image analysis method based on topological and fractal parameters to evaluate the angiostatic activity of docetaxel by using the Matrigel assay in vitro.
Guidolin D; Vacca A; Nussdorfer GG; Ribatti D
Microvasc Res; 2004 Mar; 67(2):117-24. PubMed ID: 15020202
[TBL] [Abstract][Full Text] [Related]
28. Alkylphospholipids inhibit capillary-like endothelial tube formation in vitro: antiangiogenic properties of a new class of antitumor agents.
Zerp SF; Vink SR; Ruiter GA; Koolwijk P; Peters E; van der Luit AH; de Jong D; Budde M; Bartelink H; van Blitterswijk WJ; Verheij M
Anticancer Drugs; 2008 Jan; 19(1):65-75. PubMed ID: 18043131
[TBL] [Abstract][Full Text] [Related]
29. Effects of lipoxin A(4) on CoCl(2)-induced angiogenesis and its possible mechanisms in human umbilical vein endothelial cells.
Liu S; Wu P; Ye D; Huang Y; Zhou X; Li Y; Cai L
Pharmacology; 2009; 84(1):17-23. PubMed ID: 19478549
[TBL] [Abstract][Full Text] [Related]
30. Anti-angiogenic activity of carebastine: a plausible mechanism affecting airway remodelling.
De Luisi A; Mangialardi G; Ria R; Acuto G; Ribatti D; Vacca A
Eur Respir J; 2009 Oct; 34(4):958-66. PubMed ID: 19357149
[TBL] [Abstract][Full Text] [Related]
31. In vitro model of a vascular stroma for the engineering of vascularized tissues.
Frerich B; Lindemann N; Kurtz-Hoffmann J; Oertel K
Int J Oral Maxillofac Surg; 2001 Oct; 30(5):414-20. PubMed ID: 11720044
[TBL] [Abstract][Full Text] [Related]
32. Luminacins: a family of capillary tube formation inhibitors from Streptomyces sp. II. Biological activities.
Wakabayashi T; Kageyama-Kawase R; Naruse N; Funahashi Y; Yoshimatsu K
J Antibiot (Tokyo); 2000 Jun; 53(6):591-6. PubMed ID: 10966074
[TBL] [Abstract][Full Text] [Related]
33. Rational design, structure, and biological evaluation of cyclic peptides mimicking the vascular endothelial growth factor.
Goncalves V; Gautier B; Coric P; Bouaziz S; Lenoir C; Garbay C; Vidal M; Inguimbert N
J Med Chem; 2007 Oct; 50(21):5135-46. PubMed ID: 17900101
[TBL] [Abstract][Full Text] [Related]
34. In vitro assay of angiogenesis: inhibition of capillary tube formation.
McGonigle S; Shifrin V
Curr Protoc Pharmacol; 2008 Dec; Chapter 12():Unit12.12. PubMed ID: 22294219
[TBL] [Abstract][Full Text] [Related]
35. Effects of a moderate-intensity static magnetic field on VEGF-A stimulated endothelial capillary tubule formation in vitro.
Okano H; Onmori R; Tomita N; Ikada Y
Bioelectromagnetics; 2006 Dec; 27(8):628-40. PubMed ID: 16838273
[TBL] [Abstract][Full Text] [Related]
36. Influence of angiogenesis inhibitors on endothelial cell morphology in vitro.
Friis T; Hansen AB; Houen G; Engel AM
APMIS; 2006 Mar; 114(3):211-24. PubMed ID: 16643188
[TBL] [Abstract][Full Text] [Related]
37. Indirubin shows anti-angiogenic activity in an in vivo zebrafish model and an in vitro HUVEC model.
Alex D; Lam IK; Lin Z; Lee SM
J Ethnopharmacol; 2010 Sep; 131(2):242-7. PubMed ID: 20488232
[TBL] [Abstract][Full Text] [Related]
38. Primary study on transplantation of endothelialized dermal equivalents into normal rats.
Zhou J; Liu L; Li X; Chen H; Zhang Q
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(4):377-90. PubMed ID: 17701484
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis.
Segura I; Serrano A; De Buitrago GG; González MA; Abad JL; Clavería C; Gómez L; Bernad A; Martínez-A C; Riese HH
FASEB J; 2002 Jun; 16(8):833-41. PubMed ID: 12039865
[TBL] [Abstract][Full Text] [Related]
40. Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo.
Xiao D; Singh SV
Cancer Res; 2007 Mar; 67(5):2239-46. PubMed ID: 17332354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
